Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 1493325

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1493325

U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 70 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

U.S. In Vitro Fertilization Market Growth & Trends:

The U.S. in vitro fertilization market size is anticipated to reach USD 7.24 billion by 2030, expanding at a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infertility among couples, the continuous advancements in IVF technology and techniques, and the shift in societal norms and attitudes toward family have significantly contributed to the increasing demand for IVF services in the U.S.

The regulatory landscape surrounding assisted reproductive technologies, including IVF, also influences market dynamics. Regulations governing IVF practices, clinic accreditation standards, and ethical considerations impact the accessibility and quality of IVF services in the U.S. Changes in regulations can either facilitate or hinder market growth by affecting factors such as treatment costs, clinic operations, and patient safety.

Increased public awareness about infertility issues and available treatment options has played a crucial role in driving the growth of the U.S. IVF market. Educational campaigns, media coverage, and advocacy efforts have helped destigmatize infertility and promote understanding about fertility treatments like IVF. Greater awareness empowers individuals to make informed decisions about seeking fertility assistance through IVF.

U.S. In Vitro Fertilization Market Report Highlights:

  • Based on instruments, the culture media segment dominated the market with around 40% share in 2023 owing to as availability of funding and an increase in research activities
  • The disposable devices segment is expected to grow at the fastest CAGR over the forecast period
  • Based on procedure type, the fresh non-donor segment held the largest market share of over 45% in 2023. Fresh cycles are often perceived as more cost-effective due to potentially requiring fewer treatment cycles to achieve a successful pregnancy
  • Frozen donors are expected to register the fastest CAGR during the forecast period owing to the convenience and flexibility offered by them
  • The fertility clinics segment dominated the market with around 80% share in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • The increasing demand for ART treatments has led to a significant rise in the number of fertility clinics and ART centers
  • In October 2023, Merck & Co. announced the launch of Fertility benefit program with the aim to provide financial services to employees for fertility treatments. The range of services includes IVF treatments, fertility tests, and hormonal treatments
Show more
Product Code: GVR-4-68040-278-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Instrument
    • 1.2.2. Procedure type
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Instrument outlook
    • 2.2.2. Procedure type
    • 2.2.3. End-use
  • 2.3. Competitive Insights

Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. In Vitro Fertilization Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis

  • 4.1. Instrument Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Disposable media
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Culture media
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Cryopreservation Media
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Embryo culture media
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Ovum Processing Media
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.5. Sperm Processing Media
      • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Capital Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Sperm Analyzer Systems
      • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Imaging Systems
      • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Ovum Aspiration Pumps
      • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Micromanipulator Systems
      • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Incubators
      • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.7. Gas Analyzers
      • 4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.8. Laser Systems
      • 4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.9. Cryosystems
      • 4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.10. Sperm Separation Devices
      • 4.4.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.11. IVF Cabinets
      • 4.4.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.12. Anti-vibration Tables
      • 4.4.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.13. Witness Systems
      • 4.4.3.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.14. Other
      • 4.4.3.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Procedure Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Fresh Donor
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Frozen Donor
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Fresh Non-donor
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Frozen Non-donor
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. In Vitro Fertilization Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Fertility Clinics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Hospitals & Others Setting
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Bayer AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Cook Medical LLC
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. EMD Serono, Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Ferring B.V.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Genea Biomedx
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. EMD Serono, Inc. (Merck KGaA)
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Merck & Co., Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. The Cooper Companies, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Thermo Fisher Scientific, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Vitrolife
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Nova IVF
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiativesc
    • 7.4.13. RMA Network (Reproductive Medicine Associates)
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. U.S. Fertility
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-278-5

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. in vitro fertilization market, by instrument, 2018 - 2030 (USD Million)
  • Table 3 U.S. in vitro fertilization market, by procedure type, 2018 - 2030 (USD Million)
  • Table 4 U.S. in vitro fertilization market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. in vitro fertilization market: market outlook
  • Fig. 9 U.S. in vitro fertilization competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. in vitro fertilization market driver impact
  • Fig. 14 U.S. in vitro fertilization market restraint impact
  • Fig. 15 U.S. in vitro fertilization market: Instrument movement analysis
  • Fig. 16 U.S. in vitro fertilization market: Instrument outlook and key takeaways
  • Fig. 17 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Disposable devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Culture Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cryopreservation media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Embryo culture media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Ovum processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Sperm processing media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Capital equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Sperm analyzer systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Imaging systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ovum aspiration pumps market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Micromanipulator market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Gas analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Laser systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cryosystems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Sperm separation devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 IVF cabinets market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti - vibration tables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Witness systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. in vitro fertilization market: Procedure type movement Analysis
  • Fig. 39 U.S. in vitro fertilization market: Procedure type outlook and key takeaways
  • Fig. 40 Surgical ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Fresh donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Frozen donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Fresh non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Frozen non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. in vitro fertilization market: End - use outlook and key takeaways
  • Fig. 46 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals and other settings market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!